Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-13T16:45:08.124Z Has data issue: false hasContentIssue false
  • English
  • Français

Association of KRAS gene mutations with depression in older metastatic colorectal cancer patients

Published online by Cambridge University Press:  29 July 2016

Yi Zhou ,
Xiaohui Gu ,
Feng Wen ,
Jing Chen ,
Wen Wei ,
Zhi-Hui Zhang ,
Yanting He  and
Lan Xie
Yi Zhou
Affiliation:
The Department of Gynecology & Obstetrics, Hospital of the University of Electronic Science and Technology of China and Sichuan Provincial People's Hospital, Chengdu, China
Xiaohui Gu
Affiliation:
Department of Geriatrics, Hospital of the University of Electronic Science and Technology of China and Sichuan Provincial People's Hospital, Chengdu, China
Feng Wen
Affiliation:
The Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
Jing Chen
Affiliation:
Oncology Department, Sichuan Cancer Hospital, Chengdu, China
Wen Wei
Affiliation:
Oncology Department, Sichuan Cancer Hospital, Chengdu, China
Zhi-Hui Zhang
Affiliation:
Oncology Department, Sichuan Cancer Hospital, Chengdu, China
Yanting He
Affiliation:
The Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
Lan Xie*
Affiliation:
The Department of Gynecology & Obstetrics, Hospital of the University of Electronic Science and Technology of China and Sichuan Provincial People's Hospital, Chengdu, China
*
Correspondence should be addressed to: Dr Lan Xie, The Department of Gynecology & Obstetrics, Hospital of the University of Electronic Science and Technology of China and Sichuan Provincial People's Hospital, Chengdu, China. Phone: +86-28-87393999; Fax: +86-28-87393999. E-mail: 841423692@163.com.
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Cancer patients with depression or anxiety have poor survival, and the interaction between mental and physical problems in older patients may exacerbate this problem. K-ras oncogene (KRAS) mutation may play a role in the development of psychosocial distress and may be associated with poor survival of metastatic colorectal cancer (mCRC) patients. This study investigated the association between KRAS gene mutations and psychosocial morbidity to explore the possible cancer/psychosis relationship in older mCRC patients.

Methods:

In this study, 62 newly diagnosed mCRC patients were recruited and completed the Hospital Anxiety and Depression Scale (HADS). Demographic data were also collected, and clinicopathological data were retrieved from medical records. KRAS mutations were assessed via PCR analysis of tissue specimens from the patients.

Results:

The results showed that 28 of the 62 participants (45.2%) had positive screens for possible depression, and 45 of the 62 participants (72.6%) had positive screens for anxiety. The KRAS mutation rate was 40.3% (25/62), and 19 of the 25 patients with KRAS mutations (76.0%) had probable depression, whereas only 24.3% of the patients with wild-type KRAS were probably depressed (p < 0.05). The KRAS mutation was associated with higher HADS depression scores, independent of gender and performance status (p < 0.05), but not with higher HADS anxiety or total scores.

Conclusions:

KRAS mutations were associated with depression severity and higher rates of probable depression in older mCRC patients. Depression should be assessed and treated as early as possible in older mCRC patients with the KRAS mutation. Further studies are needed to verify our current findings using a larger sample size.

Keywords

colorectal cancerdepressionKRASgene mutationgeriatrics
Type
Research Article
Information
International Psychogeriatrics , Volume 28 , Issue 12 , December 2016 , pp. 2019 - 2028
Copyright
Copyright © International Psychogeriatric Association 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aapro, S., Kohne, C., Cohen, J. and Extermann, M. (2005). Never too old? age should not be a barrier to enrollment in cancer clinical trials. Oncologist, 10, 198–204.Google Scholar
Aarstad, J., Aarstad, K., Heimdal, H. and Olofsson, J. (2005). Mood, anxiety and sense of humor in head and neck cancer patients in relation to disease stage, prognosis and quality of life. Acta Otolaryngol, 125, 557–565.CrossRefGoogle ScholarPubMed
Akizuki, N., Yamawaki, S., Akechi, T., Nakano, T. and Uchitomi, Y. (2005). Development of an impact thermometer for use in combination with the distress thermometer as a brief screening tool for adjustment disorder and/or major depression in cancer patients. Journal Pain Symptom Manage, 29, 91–99.CrossRefGoogle ScholarPubMed
Allegra, J. et al. (2009). American society of clinical oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. Journal of Clinical Oncology, 27, 2091–2096.Google Scholar
Astrom, M. (1996). Generalised anxiety disorder in stroke patients. Stroke, 27, 270–275.CrossRefGoogle ScholarPubMed
Blazer, D. (1989). Depression in the elderly. New England Journal of Medicine, 320, 164–168.Google Scholar
Blume, A., Bosch, O. J., Miklos, S., Torner, L. and Wales, L. (2008). Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus. European Journal of Neuroscience, 27, 1947–1956.Google Scholar
Breivik, J., Meling, I., Spurkland, A., Rognum, O. and Gaudernack, G. (1994). K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location. British Journal Cancer, 69, 367–371.Google Scholar
Brewer, K. (2008). Behavioral genetics of the depression/cancer correlation: a look at the Ras oncogene family and the ‘cerebral diabetes paradigm. Journal of Molecular Neuroscience, 35, 307–322.CrossRefGoogle Scholar
Bryant, C., Jackson, H. and Ames, D. (2009). Depression and anxiety in medically unwell older adults: prevalence and short-term course. International Psychogeriatrics, 21, 754–763.CrossRefGoogle ScholarPubMed
Chan, M., Wan Ahmad, A., Md Yusof, M., Ho, F. and Krupat, E. (2015). Effects of depression and anxiety on mortality in a mixed cancer group: a longitudinal approach using standardised diagnostic interviews. Psychooncology, 24, 718–725.CrossRefGoogle Scholar
Dwivedi, Y., Rizavi, H. S., Conley, R. R. and Pandey, G. N. (2006). ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf. Molecular Psychiatry, 11, 86–98.Google Scholar
Eisinger, B. E., Zhao, C., Driessen, T. M., Saul, M. C. and Gammie, S. C. (2013). Large scale expression changes of genes related to neuronal signaling and developmental processes found in lateral septum of postpartum outbred mice. PLoS One, 8, e63824.CrossRefGoogle ScholarPubMed
Esteller, M. (2001). K-ras and p16 aberrations confer poor prognosis in human colorectal cancer. Journal of Clinical Oncology, 19, 299–304.Google Scholar
Folprecht, G. et al. (2004). Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials. Annals of Oncology, 15, 1330–1338.Google Scholar
Freidrich, N., Smith, K., Harrison, D., Colwell, A., Davis, K. and Fefer, A. (1987). MMPI study of identical twins: cancer patients and bone marrow donors. Psychological Reports, 61, 127–130.Google Scholar
Fukushima, N. and Fukayama, M. (2007). Mucinous cystic neoplasms of the pancreas: pathology and molecular genetics. Journal of Hepato-Biliary-Pancreatic Surgery, 14, 238–242.CrossRefGoogle ScholarPubMed
Gill, D. and Hatcher, S. (2000). Antidepressants for depression in people with physical illness. Cochrane Database System Reviews, 2, CD001312.Google Scholar
Goodwin, S., Zhang, D. and Ostir, V. (2004). Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. Journal of the American Geriatrics Society, 52, 106–111.CrossRefGoogle ScholarPubMed
Gripp, S. et al. (2007). Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. Journal of Clinical Oncology, 25, 3313–3320.CrossRefGoogle ScholarPubMed
Guanti, G. et al. (2000). Involvement of PTEN mutations in the genetic pathways of colorectal carcinogenesis. Human Molecular Genetics, 9, 283–287.CrossRefGoogle Scholar
Ibbotson, T., Maguire, P., Selby, P., Priestman, T. and Wallace, L. (1994). Screening for anxiety and depression in cancer patients: the effects of disease and treatment. European Journal of Cancer, 30, 37–40.CrossRefGoogle Scholar
Kendler, K. and Prescott, C. (1999). A population based twin study of lifetime major depression in men and women. Archives of General Psychiatry, 56, 39–44.CrossRefGoogle ScholarPubMed
Kuo, R., Cheng, H., Chen, Y. S. and Chio, C. C. (2013). Involvement of extracellular signal regulated kinases in traumatic brain injury-induced depression in rodents. Journal of Neurotrauma, 30, 1223–1231.Google Scholar
Kvaal, K., Laake, K. and Engedal, K. (2001b). Psychometric properties of the state part of the Spielberger State-Trait Anxiety Inventory (STAI) in geriatric patients. International Journal of Geriatric Psychiatry, 16, 980–986.CrossRefGoogle ScholarPubMed
Leung, M., Ho, S., Kan, S., Hung, H. and Chen, N. (1993). Evaluation of the Chinese version of hospital anxiety and depression scale. A cross-cultural perspective. International Journal of Psychosomatics, 40, 29–34.Google Scholar
Lonze, E. and Ginty, D. (2002). Function and regulation of CREB family transcription factors in the nervous system. Neuron, 35, 605–623.CrossRefGoogle ScholarPubMed
Martins-de-Souza, D., Maccarrone, G., Ising, M., Kloiber, S., Lucae, S. Holsboer and Maccarrone, F. G. (2014). Blood mononuclear cell proteome suggests integrin and Ras signaling as critical pathways for antidepressant treatment response. Biological Psychiatry, 76, e15–17.Google Scholar
Massie, J. (2004). Prevalence of depression in patients with cancer. Journal of the National Cancer Institute. Monographs, 32, 57–71.CrossRefGoogle Scholar
McDaniel, S., Musselman, L., Porter, R., Reed, D. A. and Nemeroff, B. (1995). Depression in patients with cancer: diagnosis, biology, and treatment. Archives of General Psychiatry, 52, 89–99.Google Scholar
Medeiros, M., Oshima, T. and Forones, M. (2010). Depression and anxiety in colorectal cancer patients. Journal of Gastrointest Cancer, 41, 179–184.CrossRefGoogle ScholarPubMed
Mitchell, J. (2007). Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. Journal of Clinical Oncology, 25, 4670–4681.Google Scholar
Pettingale, W., Burgess, C. and Greer, S. (1987). Psychological response to cancer diagnosis-I. Correlations with prognostic variables. Journal of Psychosomatic Research, 32, 255–61.Google Scholar
Pinquart, M. and Duberstein, R. (2010). Depression and cancer mortality: a meta-analysis. Psychological Medicine, 40, 1797–1810.Google Scholar
Pirl, F. et al. (2011). Tumor epidermal growth factor receptor genotype and depression in stage IV non-small cell lung cancer. Oncologist, 16, 1299–1306.Google Scholar
Qi, X. et al. (2009). A role for the extracellular signal-regulated kinase signal pathway in depressive-like behavior. Behavioural Brain Research, 199, 203–209.Google Scholar
Rabkin, G., McElhiney, M., Moran, P., Acree, M. and Folkman, S. (2009). Depression, distress and positive mood in late-stage cancer: a longitudinal study. Psychooncology, 18, 79–86.CrossRefGoogle ScholarPubMed
Ressler, J. and Nemeroff, B. (2000). Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depression and Anxiety, 12, 12–19.Google Scholar
Reyes-Gibby, C. et al. (2008). Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncology, 9, 777–785.CrossRefGoogle ScholarPubMed
Rhondali, G. et al. (2015). Agreement for depression diagnosis between DSM-IV-TR criteria, three validated scales, oncologist assessment, and psychiatric clinical interview in elderly patients with advanced ovarian cancer. Clinical Interventions in Aging, 10, 1155–1162.Google Scholar
Satin, R., Linden, W. and Phillips, J. (2009). Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer, 115, 5349–5361.CrossRefGoogle ScholarPubMed
Shin, H., Park, J. and Park, G. (2001). PTEN gene mutations in colorectal cancers displaying microsatellite instability. Cancer Letters, 174, 189–194.CrossRefGoogle ScholarPubMed
Snaith, R. and Zigmond, A. (1986). The hospital anxiety and depression scale. British Medical Journal (Clinical research ed.), 292, 344.Google Scholar
Stewart, A. L. et al. (1989). Functional status and well-being of patients with chronic conditions. Journal of the American Medical Association, 262, 907–913.Google Scholar
Stommel, M., Kurtz, E., Kurtz, C., Given, W. and Given, A. (2004). A longitudinal analysis of the course of depressive symptomatology in geriatric patients with cancer of the breast, colon, lung, or prostate. Health Psychology, 23, 564–573.Google Scholar
Thapar, A. and McGuffin, P. (1996). Genetic influences on life events in childhood. Psychological Medicine, 26, 813–820.Google Scholar
Thomas, M. and Huganir, L. (2004). MAPK cascade signalling and synaptic plasticity. Nature Reviews Neuroscience, 5, 173–183.Google Scholar
Todorovic, C., Sherrin, T., Pitts, M., Hippel, C., Rayner, M. and Spiess, J. (2009). Suppression of the MEK/ERK signaling pathway reverses depression-like behaviors of CRF2-deficient mice. Neuropsychopharmacology, 34, 1416–1426.CrossRefGoogle ScholarPubMed
Tronson, N. C., Schrick, C., Fischer, A., Sananbenesi, F., Pages, G. and Pouyssegur, J. C. (2008). Regulatory mechanisms of fear extinction and depression-like behavior. Neuropsychopharmacology, 33, 1570–1583.CrossRefGoogle ScholarPubMed
Tsunoda, A., Nakao, K., Hiratsuka, K., Yasuda, N., Shibusawa, M. and Kusano, M. (2005). Anxiety, depression and quality of life in colorectal cancer patients. International Journal of Clinical Oncology, 10, 411–417.CrossRefGoogle ScholarPubMed
VanCutsem, E. et al. (2011). Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. Journal of Clinical Oncology, 29, 2011–2019.Google Scholar
Vardy, J. et al. (2014). Cognitive function and fatigue after diagnosis of colorectal cancer. Annals of Oncology, 25, 2404–2412.CrossRefGoogle ScholarPubMed
Yancik, R. (1997). Cancer burden in the aged: an epidemiologic and demographic overview. Cancer, 80, 1273–1283.3.0.CO;2-4>CrossRefGoogle ScholarPubMed
Yuan, P., Zhou, R., Wang, Y., Li, X., Li, J. and Chen, G. (2010). Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia. Journal of Affective Disorders 124, 164–169.Google Scholar
Zhang, X., Beaulieu, M., Sotnikova, D., Gainetdinov, R. and Caron, G. (2004). Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science, 305, 217.Google Scholar